Molecular Diagnosis of Drug-Resistant Tuberculosis; A Literature Review

被引:76
|
作者
Thi Ngoc Anh Nguyen [1 ,2 ,3 ]
Anton-Le Berra, Veronique [4 ]
Banuls, Anne-Laure [1 ,3 ]
Thi Van Anh Nguyen [2 ,3 ]
机构
[1] Univ Montpellier, CNRS, Inst Res Dev, UMR MIVEGEC, Montpellier, France
[2] Natl Inst Hyg & Epidemiol, Dept Bacteriol, Lab TB, Hanoi, Vietnam
[3] Natl Inst Hyg & Epidemiol, LMI Drug Resistance South East Asia, Hanoi, Vietnam
[4] Univ Toulouse, INSA, INRA, LISBP,CNRS, Toulouse, France
来源
FRONTIERS IN MICROBIOLOGY | 2019年 / 10卷
关键词
tuberculosis; drug resistance; diagnosis; mutations; molecular markers; challenges; LINE PROBE ASSAY; REAL-TIME PCR; POINT-OF-CARE; MYCOBACTERIUM-TUBERCULOSIS; RAPID DETECTION; GENOTYPE MTBDRPLUS; MULTICENTER EVALUATION; MULTIDRUG-RESISTANCE; RIFAMPIN RESISTANCE; 2ND-LINE DRUGS;
D O I
10.3389/fmicb.2019.00794
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Drug-resistant tuberculosis is a global health problem that hinders the progress of tuberculosis eradication programs. Accurate and early detection of drug-resistant tuberculosis is essential for effective patient care, for preventing tuberculosis spread, and for limiting the development of drug-resistant strains. Culture-based drug susceptibility tests are the gold standard method for the detection of drug-resistant tuberculosis, but they are time-consuming and technically challenging, especially in low- and middle-income countries. Nowadays, different nucleic acid-based assays that detect gene mutations associated with resistance to drugs used to treat tuberculosis are available. These tests vary in type and number of targets and in sensitivity and specificity. In this review, we will describe the available molecular tests for drug-resistant tuberculosis detection and discuss their advantages and limitations.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Rapid Molecular Assays for the Diagnosis of Drug-Resistant Tuberculosis
    Nandlal, Louansha
    Perumal, Rubeshan
    Naidoo, Kogieleum
    [J]. INFECTION AND DRUG RESISTANCE, 2022, 15 : 4971 - 4984
  • [2] Will molecular diagnosis of drug-resistant tuberculosis improve patient outcomes?
    Jonsson, Greg
    Furin, Jennifer
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (01) : 4 - 5
  • [3] Extensively Drug-Resistant Tuberculosis: A Case Report and Literature Review
    de Araujo-Filho, Joao Alves
    Vasconcelos-, Arioldo Carvalho, Jr.
    de Sousa, Eduardo Martins
    da Silveira, Colombina
    Ribeiro, Elisangela
    Kipnis, Andre
    Junqueira-Kipnis, Ana Paula
    [J]. BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2008, 12 (05): : 447 - 452
  • [4] Diagnosis and Treatment of Drug-Resistant Tuberculosis
    Caminero, Jose A.
    Cayla, Joan A.
    Garcia-Garcia, Jose-Maria
    Garcia-Perez, Francisco J.
    Palacios, Juan J.
    Ruiz-Manzano, Juan
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2017, 53 (09): : 501 - 509
  • [5] Treatment of Drug-Resistant Tuberculosis: Review
    Baylan, Orhan
    [J]. TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2012, 32 (03): : 788 - 804
  • [6] Drug-resistant tuberculosis: advances in diagnosis and management
    Guenther, Gunar
    Ruswa, Nunurai
    Keller, Peter M.
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2022, 28 (03) : 211 - 217
  • [7] Recent developments in the diagnosis of drug-resistant tuberculosis
    Nicol, Mark P.
    Cox, Helen
    [J]. MICROBIOLOGY AUSTRALIA, 2019, 40 (02) : 82 - 86
  • [8] DIAGNOSIS AND TREATMENT OF DRUG-RESISTANT TUBERCULOSIS IN CHILDREN
    Seddon, Doctor James Alexander
    [J]. PEDIATRIC PULMONOLOGY, 2015, 50 : S23 - S24
  • [9] Molecular epidemiology of drug-resistant tuberculosis in Hungary
    Kodmon, Csaba
    Niemann, Stefan
    Lukacs, Judit
    Sor, Eva
    David, Sandor
    Somoskovi, Akos
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (11) : 4258 - 4261
  • [10] The future of molecular diagnostics for drug-resistant tuberculosis
    Heysell, Scott K.
    Houpt, Eric R.
    [J]. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2012, 12 (04) : 395 - 405